Meta-Analysis of Genome-Wide Association Studies of Doxorubicin-Induced Arrhythmia Identifies MMP16 and KCTD15 as Risk Loci
作者:Joseph S. Reddy, Milagros Pereyra, Mohammed Tiseer Abbas, Reza Arsanjani, Isaac E. Prah, Nicholas Boddicker, James R. Cerhan, Melissa C. Larson, Mwangi Raphael, Thomas M. Habermann, Hector R. Villarraga, Robert A. Vierkant, Anthony C. Luehrs, Hugues Sicotte, Jan B. Egan, Konstantinos N. Lazaridis, Maryam Moossavi, Xiaolei Xu, Pooja Advani, Chadi Ayoub, Nadine Norton · 发表于:Circulation Genomic and Precision Medicine · 年份:2026 · DOI:10.1161/circgen.125.005651 · 研究领域:Chemotherapy-induced cardiotoxicity and mitigation、Cardiac electrophysiology and arrhythmias、Lung Cancer Research Studies
BACKGROUND: Anthracyclines are a widely used and effective class of chemotherapy. However, a major limitation for their use is cardiotoxicity, manifesting as systolic dysfunction, congestive heart failure, and arrhythmias. The objective of this study was to identify genes and genetic risk variants for doxorubicin-induced arrhythmia. METHODS: We performed genome-wide association studies and meta-analysis across 2 independent nonoverlapping, genetically homogenous data sets from the Molecular Epidemiology Resource (cases N=77, controls N=1184) and Tapestry (cases N=13, controls N=172). Doxorubicin-related arrhythmia was the primary cardiac outcome, followed by investigation of a broader phenotype of cardiac events. Effects of doxorubicin on top-associated genes were assessed by quantitative polymerase chain reaction on RNA extracted from human cardiomyocytes following treatment with doxorubicin and by echocardiography in a zebrafish model of doxorubicin-induced cardiomyopathy. RESULTS: In the meta-analysis, rs12151014 at the KCTD15 locus was associated with doxorubicin-related arrhythmia at the genome-wide significance (minor allele frequency in Molecular Epidemiology Resource cases 0.195 versus 0.069 in controls; Tapestry cases 0.192 versus 0.079 in controls) P =9.01×10 −9 ; odds ratio, 3.61. MMP 16 rs1094199 was associated with the broader phenotype of arrhythmia and heart failure (minor allele frequency in Molecular Epidemiology Resource cases 0.079 versus 0.019 in controls;...